Skip to main content
Journal cover image

Immuno-synergy? Neoantigen vaccines and checkpoint blockade in glioblastoma.

Publication ,  Journal Article
Woroniecka, K; Fecci, PE
Published in: Neuro Oncol
September 29, 2020

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Neuro Oncol

DOI

EISSN

1523-5866

Publication Date

September 29, 2020

Volume

22

Issue

9

Start / End Page

1233 / 1234

Location

England

Related Subject Headings

  • Oncology & Carcinogenesis
  • Immunotherapy
  • Humans
  • Glioblastoma
  • Cancer Vaccines
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1109 Neurosciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Woroniecka, K., & Fecci, P. E. (2020). Immuno-synergy? Neoantigen vaccines and checkpoint blockade in glioblastoma. Neuro Oncol, 22(9), 1233–1234. https://doi.org/10.1093/neuonc/noaa170
Woroniecka, Karolina, and Peter E. Fecci. “Immuno-synergy? Neoantigen vaccines and checkpoint blockade in glioblastoma.Neuro Oncol 22, no. 9 (September 29, 2020): 1233–34. https://doi.org/10.1093/neuonc/noaa170.
Woroniecka K, Fecci PE. Immuno-synergy? Neoantigen vaccines and checkpoint blockade in glioblastoma. Neuro Oncol. 2020 Sep 29;22(9):1233–4.
Woroniecka, Karolina, and Peter E. Fecci. “Immuno-synergy? Neoantigen vaccines and checkpoint blockade in glioblastoma.Neuro Oncol, vol. 22, no. 9, Sept. 2020, pp. 1233–34. Pubmed, doi:10.1093/neuonc/noaa170.
Woroniecka K, Fecci PE. Immuno-synergy? Neoantigen vaccines and checkpoint blockade in glioblastoma. Neuro Oncol. 2020 Sep 29;22(9):1233–1234.
Journal cover image

Published In

Neuro Oncol

DOI

EISSN

1523-5866

Publication Date

September 29, 2020

Volume

22

Issue

9

Start / End Page

1233 / 1234

Location

England

Related Subject Headings

  • Oncology & Carcinogenesis
  • Immunotherapy
  • Humans
  • Glioblastoma
  • Cancer Vaccines
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1109 Neurosciences